Loading...
The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs
A vaccine that prevents hepatitis C virus (HCV) infection is urgently needed to support an emerging global elimination program. However, vaccine development has been confounded because of HCV's high degree of antigenic variability and the preferential induction of type‐specific immune responses...
Saved in:
| Published in: | Hepatology |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5408392/ https://ncbi.nlm.nih.gov/pubmed/27997681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28989 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|